Karin Schölin Bywall

Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method Study

Eline van Overbeeke, Rosanne Janssens, Chiara Whichello et al. · Frontiers in Pharmacology · 2019 · 76 citations · Full text

Public Affairs, Health Policy, Pharmaceutical Policy +17

An overview of critical decision-points in the medical product lifecycle: Where to include patient preference information in the decision-making process?

Chiara Whichello, Karin Schölin Bywall, Jonathan Mauer et al. · Health Policy · 2020 · 40 citations · Full text

Business, Health Information Management, Clinical Decision Support +16

Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USA

Rosanne Janssens, Selena Russo, Eline van Overbeeke et al. · Patient · 2019 · 38 citations · Full text

Public Affairs, Health Care Management, Health Policy +17

Patient preferences on rheumatoid arthritis second-line treatment: a discrete choice experiment of Swedish patients

Karin Schölin Bywall, Ulrik Kihlbom, Mats Hansson et al. · Arthritis Research & Therapy · 2020 · 33 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action

Rosanne Janssens, Liese Barbier, Mireille Muller et al. · Frontiers in Pharmacology · 2023 · 26 citations · Full text

Pharmacy, Pharmaceutical Policy, Drug Approval Processes +12